Shenglan Gong

641 total citations
30 papers, 447 citations indexed

About

Shenglan Gong is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Shenglan Gong has authored 30 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Shenglan Gong's work include Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Shenglan Gong is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Shenglan Gong collaborates with scholars based in China, United States and Macao. Shenglan Gong's co-authors include Jianmin Yang, Shuqing Lü, Jianmin Wang, Hong Zhou, Zhilong Chen, Lieping Guo, Li Chen, Jianmin Wang, Xiaoxia Hu and Xianmin Song and has published in prestigious journals such as Blood, Journal of Pharmacology and Experimental Therapeutics and Journal of Ethnopharmacology.

In The Last Decade

Shenglan Gong

26 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenglan Gong China 11 286 180 118 67 46 30 447
José González Spain 10 365 1.3× 297 1.6× 99 0.8× 23 0.3× 70 1.5× 25 507
P Pagliaro Italy 8 291 1.0× 148 0.8× 82 0.7× 52 0.8× 130 2.8× 12 506
Hyewon Lee South Korea 12 127 0.4× 220 1.2× 150 1.3× 31 0.5× 46 1.0× 38 424
Ming Hou China 14 188 0.7× 216 1.2× 70 0.6× 42 0.6× 26 0.6× 31 461
Beihui Huang China 11 200 0.7× 188 1.0× 120 1.0× 74 1.1× 10 0.2× 59 350
Amr Hanbali United States 9 108 0.4× 104 0.6× 74 0.6× 26 0.4× 28 0.6× 43 301
Nitya Nathwani United States 12 263 0.9× 198 1.1× 186 1.6× 11 0.2× 34 0.7× 37 528
Л. П. Менделеева Russia 7 155 0.5× 154 0.9× 93 0.8× 16 0.2× 17 0.4× 81 333
Lidija Dokmanović Serbia 13 145 0.5× 114 0.6× 88 0.7× 22 0.3× 163 3.5× 47 419
William Koss United States 9 139 0.5× 62 0.3× 157 1.3× 38 0.6× 36 0.8× 19 426

Countries citing papers authored by Shenglan Gong

Since Specialization
Citations

This map shows the geographic impact of Shenglan Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Gong more than expected).

Fields of papers citing papers by Shenglan Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Gong. The network helps show where Shenglan Gong may publish in the future.

Co-authorship network of co-authors of Shenglan Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Gong. A scholar is included among the top collaborators of Shenglan Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Gong. Shenglan Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Meng, Xin, Shenglan Gong, Xiao‐Bin Jia, et al.. (2025). Ginsenoside Rg1 mitigates the prolonged isoflurane anesthesia-induced neuroimmune disruptions. Journal of Ethnopharmacology. 353(Pt B). 120327–120327.
3.
Fan, Yawen, Jinxian Zhu, Mengni Wang, et al.. (2023). Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure. Frontiers in Cellular and Infection Microbiology. 13. 1135428–1135428. 10 indexed citations
4.
5.
Wang, Ziwei, Yuesheng Zhang, Xiong Ni, et al.. (2022). Cytogenetic evolution predicts a poor prognosis in acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 102(1). 89–97. 1 indexed citations
6.
Xie, Xiaoxue, Shenglan Gong, Hekun Jin, et al.. (2020). Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count. Radiation Oncology. 15(1). 65–65. 33 indexed citations
7.
Gong, Shenglan, et al.. (2020). Fraction of Exhaled Nitric Oxide Is Elevated in Patients With Stable Chronic Obstructive Pulmonary Disease: A Meta-analysis. The American Journal of the Medical Sciences. 360(2). 166–175. 4 indexed citations
8.
9.
Gong, Shenglan, et al.. (2018). Overexpression of TEL-MN1 Fusion Enhances Resistance of HL-60 Cells to Idarubicin. Chemotherapy. 63(6). 308–314. 1 indexed citations
10.
Qiu, Huiying, Shenglan Gong, Lili Xu, et al.. (2018). MYD88 L265P mutation promoted malignant B cell resistance against T cell-mediated cytotoxicity via upregulating the IL-10/STAT3 cascade. International Immunopharmacology. 64. 394–400. 9 indexed citations
11.
Cheng, Hui, Chongmei Huang, Xiaoxia Hu, et al.. (2017). PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia. Journal of Translational Medicine. 15(1). 179–179. 18 indexed citations
12.
13.
Tang, Gusheng, Jun Wu, Hui Chen, et al.. (2015). BCR-ABL1 and CD66c exhibit high concordance in minimal residual disease detection of adult B-acute lymphoblastic leukemia.. PubMed. 7(3). 632–9. 13 indexed citations
14.
15.
He, Guoqian, et al.. (2013). Status and costs of primary prevention for ischemic stroke in China. Journal of Clinical Neuroscience. 20(10). 1427–1432. 15 indexed citations
16.
Wang, Jianmin, et al.. (2010). [A novel single nucleotide polymorphism-based method for quantitative assessment of chimerism after allogeneic stem cell transplantation.].. PubMed. 31(2). 92–6. 2 indexed citations
17.
Gong, Shenglan, et al.. (2010). [Clinical and laboratory study of myleodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) with PDGFRβ abnormalities].. PubMed. 31(8). 540–4.
18.
Lü, Shuqing, Jianmin Yang, Zhilong Chen, et al.. (2009). Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line. Experimental Hematology. 37(7). 831–837. 67 indexed citations
19.
Lü, Shuqing, Zhilong Chen, Jianmin Yang, et al.. (2008). Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line. Experimental Hematology. 36(10). 1278–1284. 71 indexed citations
20.
Song, Xianmin, Shenglan Gong, Jianmin Yang, & Jianmin Wang. (2007). Clinical and molecular cytogenetic characteristics of dic(9;20) in adult acute lymphoblastic leukemia: a case report of three patients. Annals of Hematology. 86(5). 347–351. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José González Breakdown of academic impact, for papers by P Pagliaro Breakdown of academic impact, for papers by Hyewon Lee Breakdown of academic impact, for papers by Ming Hou Breakdown of academic impact, for papers by Beihui Huang Breakdown of academic impact, for papers by Amr Hanbali Breakdown of academic impact, for papers by Nitya Nathwani Breakdown of academic impact, for papers by Л. П. Менделеева Breakdown of academic impact, for papers by Lidija Dokmanović Breakdown of academic impact, for papers by William Koss
Rankless by CCL
2026